Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. On Thursday, Cathie Wood-led Ark Invest made a significant move by offloading shares of Moderna Inc (NASDAQ:MRNA). This decision comes amidst a backdrop of mixed analyst sentiments and Moderna’s recently unveiled post-COVID roadmap. Don’t Miss: A billion-dollar investment strategy with minimums as low as $10 — you can become part of the next big real estate boom today. This is a paid advertisement. Carefully consider the investment objectives, risks, charges and expenses of the Fundrise Flagship Fund before investing. This and other information can be found in the Fund's prospectus. Read them carefully before investing. Powell’s moves don’t have to doom your high yields. You can still make great returns in private credit. Find out how. The Moderna Trade Ark Invest’s ARK Genomic Revolution ETF (BATS:ARKG) and ARK Innovation ETF (nyse:ARKK) sold a total of 160,994 shares of Moderna. The value of the trade, based on Moderna’s closing price of $56.83 on the day of the trade, is approximately $9.15 million. Moderna’s stock has been under scrutiny following its recent announcement of a revised financial plan and updates to its mRNA-based pipeline. CEO Stéphane Bancel highlighted the company’s success in respiratory vaccines and outlined a focus on five non-respiratory products aiming for approvals by 2027. However, the biotech company’s future prospects have elicited mixed reactions from analysts. Over the past three months, 16 analysts have shared their evaluations, with the average 12-month price target standing at $111.50, a decrease of 18.06% from the previous average. Trending:This billion-dollar fund has invested in the next big real estate boom, here's how you can join for $10.This is a paid advertisement. Carefully consider the investment objectives, risks, charges and expenses of the Fundrise Flagship Fund before investing. This and other information can be found in the Fund's prospectus. Read them carefully before investing. Other Key Trades: ARK Autonomous Technology & Robotics ETF (ARKQ) bought 3,589 shares of Advanced Micro Devices Inc (AMD) worth $589,242. Ark Invest’s ARKG and ARKK bought a total of shares of 10X Genomics Inc (TXG). ARKK also purchased shares of CRISPR Therapeutics AG (CRSP). Blade Air Mobility Inc (BLDE), and 3D Systems Corp (DDD) while selling shares of Materialise NV (MTLS) and Markforged Holding Corp (MKFG). Wondering if your investments can get you to a $5,000,000 nest egg? Speak to a financial advisor today. SmartAsset’s free tool matches you up with up to three vetted financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. Keep Reading: Your biggest returns may not come from the stock market. Invest the way colleges, pension funds, and the 1% do. Get started investing in commercial real estate today. Interest rates are falling but you can still make high yields in real estate. Find out how. This article Cathie Wood's Ark Invest Dumps Over $9M In Moderna Stock — Even With Post-COVID Plans On The Table originally appeared on Benzinga.com
Cathie Wood's Ark Invest Dumps Over $9M In Moderna Stock — Even With Post-COVID Plans On The Table
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...